Yekaterina Chudnovsky
Director/Board Member bei ELICIO THERAPEUTICS, INC.
Vermögen: 10 Mio $ am 31.03.2024
Ursprung des Netzwerks ersten Grades von Yekaterina Chudnovsky
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 16 | |
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA.
12
| Subsidiary | Biotechnology | 12 |
| Public Company | Pharmaceuticals: Major | 9 | |
xCures, Inc.
 xCures, Inc. Packaged SoftwareTechnology Services xCures, Inc. engages in the development of artificial intelligence (AI) based precision oncology platform. It offers patients and physicians an individualized treatment options and facilitates access via reimbursement, clinical trials, and access support. The company was founded by Jeff Shrager and Jay Marty Tenenbaum in 2018 and is headquartered in Los Altos, CA.
7
| Holding Company | Packaged Software | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Yekaterina Chudnovsky
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ALZA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
ACM Capital Partners LLC
 ACM Capital Partners LLC Investment ManagersFinance ACM Capital Partners LLC provides investments services. The company is headquartered in Miami, FL. | Investment Managers | Corporate Officer/Principal | |
eXIthera Pharmaceuticals, Inc.
 eXIthera Pharmaceuticals, Inc. BiotechnologyHealth Technology eXIthera Pharmaceuticals, Inc. develops and manufactures stroke prevention and antithrombosis drugs. Its drugs are based on the pathophysiological role of Factor XI in the initiation of intravascular thrombi without causing undue bleeding. The firm’s drug candidates are small, orally active, and highly selective Factor XI inhibitors. The company was founded by Neil J. Hayward and Frans L. Stassen in 2012 and is headquartered in Westborough, MA. | Biotechnology | Director/Board Member Director/Board Member | |
Transplant Genomics, Inc.
 Transplant Genomics, Inc. BiotechnologyHealth Technology Transplant Genomics, Inc. operates as a molecular diagnostic company. It develops molecular diagnostic tests that detect early signs of graft injury, differentiate among actionable causes and enable optimization of therapy. The company was founded by Daniel Salomon in 2013 and is headquartered in Mansfield, MA. | Biotechnology | Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Stanford University | College/University | Doctorate Degree Graduate Degree Corporate Officer/Principal Undergraduate Degree | |
| University of Pennsylvania | College/University | Undergraduate Degree | |
Afferent Systems, Inc.
 Afferent Systems, Inc. Packaged SoftwareTechnology Services Part of Dassault Systèmes SA, Afferent Systems, Inc. develops software for the healthcare industry. The private company is based in San Francisco, CA. Afferent Systems was acquired by MDL Information Systems, Inc., part of Dassault Systèmes SA from October 02, 2007 on July 19, 2001. | Packaged Software | Corporate Officer/Principal | |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor Corporate Officer/Principal | |
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Financial Conglomerates | President Chief Executive Officer | |
CommerceNet
 CommerceNet Internet Software/ServicesTechnology Services CommerceNet develops business forums to facilitate international business-to-business electronic trade, Its portfolio companies include Powerset, CommunityWalk and GigaLogix. The company was founded by Jay M. Tenenbaum, Michael Genesereth, and Jeff Shrager in 1994 and is headquartered in Los Altos, CA. | Internet Software/Services | Founder | |
| University of California, Los Angeles | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree Masters Business Admin | |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| National University | College/University | Masters Business Admin | |
| University of California, Davis | College/University | Undergraduate Degree | |
University of Houston
 University of Houston Other Consumer ServicesConsumer Services University of Houston System offers higher education degrees and job training or vocational study programs. It offers about 280 undergraduate and graduate degree programs in fields such as business, education, humanities and law. It was founded in 1927 and is headquartered in Houston, TX. | College/University | Undergraduate Degree | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Brookside Mezzanine Partners Management LLC
 Brookside Mezzanine Partners Management LLC Investment ManagersFinance Brookside Mezzanine Partners Management LLC (Brookside Capital Partners) is a private equity firm founded in 1977 by John N Irwin and David D Buttolph. The firm is headquartered in Stamford, Connecticut. | Investment Managers | Director/Board Member | |
Tangerine Technologies, Inc.
 Tangerine Technologies, Inc. Packaged SoftwareTechnology Services Tangerine Technologies, Inc. provides software development and business process outsourcing solutions. The company was founded by Jay Venkatesan and Todd Riley Johnson in 1999 and is headquartered in Santa Clara, CA. | Packaged Software | Founder | |
Clal Biotechnology Industries Ltd. (Venture Capital)
 Clal Biotechnology Industries Ltd. (Venture Capital) Investment ManagersFinance Clal Biotechnology Industries Ltd. (Clal Biotechnology Industries) is a venture capital division of Clal Biotechnology Industries Ltd. founded in 1993. The firm is headquartered in Tel Aviv, Israel. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Harvard Medical School | College/University | Doctorate Degree | |
San Diego Athena
 San Diego Athena Miscellaneous Commercial ServicesCommercial Services San Diego Athena operates as a not-for-profit organization. It supports and develops women. The company was founded by Barbara Bry in 1998 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
CN Ventures LLC
 CN Ventures LLC Investment ManagersFinance CN Ventures LLC (CN Ventures) is a venture capital subsidiary of CommerceNet founded in 2000. The firm is headquartered in Palo Alto, California. | Investment Managers | Founder Chief Tech/Sci/R&D Officer | |
| Ayer Capital Partners Master Fund LP | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Exicure Operating Co.
 Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Pharmaceuticals: Major | Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
Nexcella, Inc.
 Nexcella, Inc. BiotechnologyHealth Technology Part of Immix Biopharma, Inc., Nexcella, Inc. is a clinical-stage biopharmaceutical company based in Los Angeles, CA. The private company is engaged in the discovery and development of novel cell therapies for oncology and other indications. Nexcella's lead candidate, next generation bcma-targeted car-t nxc-201, has produced high response rates in relapsed/refractory al amyloidosis and relapsed/refractory multiple myeloma, and has been awarded orphan drug designation by the FDA in both indications. The company's n-genius platform allows for the discovery, development, and manufacture of cutting-edge cell therapies for patients in need. Expansion into autoimmune indications is planned. | Biotechnology | Chairman President | |
MatriSys Bioscience, Inc.
 MatriSys Bioscience, Inc. BiotechnologyHealth Technology MatriSys Bioscience, Inc. engages in the development of biologic therapeutics. It offers therapies for dermatology and skin care conditions including atopic dermatitis, rosacea, psoriasis, acne, and skin infections. The company was founded by Mark S. Wilson and Richard L. Gallo in 2015 and is headquartered in La Jolla, CA. | Biotechnology | Chairman Director/Board Member | |
| ATARA BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | ||
| EXICURE, INC. | Biotechnology | Director/Board Member | |
| ALPINE IMMUNE SCIENCES, INC. | Biotechnology | President | |
Janssen Oncology, Inc.
 Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University of Pennsylvania Medical Center | College/University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 42 |
| Israel | 3 |
| Vereinigtes Königreich | 2 |
| Cayman Islands | 2 |
Sektoral
| Health Technology | 21 |
| Consumer Services | 11 |
| Finance | 8 |
| Technology Services | 5 |
| Commercial Services | 4 |
Operativ
| Director/Board Member | 183 |
| Corporate Officer/Principal | 91 |
| Independent Dir/Board Member | 40 |
| Undergraduate Degree | 35 |
| Founder | 32 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Karen Wilson | 31 |
| Magda Marquet | 30 |
| Laurence Marton | 30 |
| Jay Venkatesan | 30 |
| Robert Ruffolo | 24 |
| Julian Adams | 22 |
| Moe Kermani | 20 |
| Assaf Segal | 19 |
| Jane Buchan | 17 |
| Allen Nissenson | 17 |
| George Hoyem | 17 |
| Helen Adams | 17 |
| Robert Connelly | 15 |
| Jay Tenenbaum | 14 |
| Jason Hsu | 14 |
- Börse
- Insiders
- Yekaterina Chudnovsky
- Unternehmensverbindungen
